San Diego Brain Injury Foundation

bulletAbout Us
bulletBrain Injury Guide
bulletEn Espaņol
bulletNewsletter
bulletUpcoming Events
bulletSDBIF Media
bulletArticles
bullet Speakers Series
bullet Map
bullet North County Speakers Series
bullet Map
bulletSupport Groups, Classes & Services
bullet Howard House
bulletOnline Resources
bullet Job Board
bulletMembership
bulletSearch Page
bullet Donations

You help a lot, even when you help a little.
Please make a donation to SDBIF online now.

 

BRAIN INJURY MEDICATIONS

by Daniel Gardner, M.D. (copyright 9/94, 8/98)

(This article may be reprinted and distributed freely provided the text is unchanged and full attribution is given to the author.)

*** PLEASE CONSULT WITH YOUR PHYSICIAN BEFORE MAKING ANY CHANGES IN YOUR CURRENT MEDICATION OR ADDING ANY NEW MEDICATIONS!***

The following list of medications used for brain injury-related problems is based on the medical literature and my clinical experience.

CLINICAL INDICATIONS:

Disorders in the following areas:

Aggression, Anxiety, Arousal, Autonomic regulation, Cognition, Conceptual disorder,

Eating, Headache, Mood Movement, Obsessions-compulsions, Perception, Seizures,

Sexual function, Sleep, Speech-language

AGGRESSION:

Anticonvulsants

Carbamazepin, Valproic acid, Clonazepam, Gabapentin, Lamictal, Topiramate

Neuroleptics

Fluphenazine, Pimozide (especially for negative symptoms; check EKG at start and each dose increase over 10 mg/day), Clozaril (no extra-pyramidal side effects (EPS), but hypotension, hypersalivation, sedation , agranulocytosis)

Risperidone (low EPS), Olanzepine, Quetiapine

Medroxyprogesterone

Lithium carbonate

Amantadine (100 mg up to 100mg qid)

Beta adrenergic blockers

Inderal, Pindolol (up to 60 mg daily; less hypotension secondary to intrinsic sympathomimetic activity)

Calcium Channel Blockers

Verapamil (up to 80 mg. qid), Diltiazem, Nifedipine,

Nimodipine (selective for cerebral vasculature)

Antidepressants

Fluoxetine, Sertraline, Paroxetine, Trazodone, Nortriptyline, Desipramine

Amoxapine (metabolized to a neuroleptic), Nefazodone, Mirtazapine

Anti-anxiety medications

Buspirone, Alprazolam, Clonazepam, Lorazepam

Clonidine (hypotension and sedation; .05-.1 mg bid--starting dose. Increase by .1 mg/d, maximum dose = 2.4 mg/d)

Stimulants

Methylphenidate, Dextroamphetamine, Magnesium Pemoline, Adderall

Antihistamines

Hydroxyzine

Anticholinergics

Benztropine, Scopolamine

Dextromethorphan (sustained release) (60-90mg bid)

ANXIETY :

ANXIETY, SOMATIC PREOCCUPATION, HYPOCHONDRIASIS:

Antidepressants, Buspirone, Alprazolam, Clonazepam, Lorazepam

POST-TRAUMATIC STRESS DISORDER:

Tricyclic antidepressants:

Imipramine, Nortriptyline

Selective serotonin reuptake inhibitor antideptressants:

Fluoxetine, Sertraline, Paroxetine

Monoamine oxidase inhibitor antidepressants:

Phenylzine, Parnate

Anti-anxiety agents:

Alprazolam, Lorazepam

Beta-adrenergic blockers: Propranolol, Atenolol

Anticonvulsants: Carbamazepine

AROUSAL:

COMA RECOVERY:

L-Dopa, Amphetamine, Hyperbaric oxygen, Naloxone

"Coma Cocktail"

Neurotransmitter precursors

Vitamin C 100 mg, Co-Enzyme Q10 2400 mg tid, L-Tyrosine 2000 mg/day for one week then add

Bromocriptine 2.5 mg tid up to 30 mg/d (check bp) (or may use L-Dopa), then Dextroamphetamine 5 mg twice daily up to 20 mg/day,then

Scopolamine patch (to block muscarinic receptors) behind alternating ears q3d (.5 mg/d) (Allen Childs, unpublished)

LACK OF INITIATIVE, APATHY, IMPAIRED ATTENTION AND MEMORY, HYPERACTIVITY:

Amphetamine (avoid abrupt withdrawal, leading to depression)

Bromocriptine, Pergolide, L-Dopa/Carbidopa

Amantadine (100-400 mg. per day, especially in patients with Parkinsonian symptoms of bradykinesia, rigidity, tremor, reduced spontaneity and initiation) Fluoxetine, Sertraline, Paroxetine, Selegiline 5 mg bid, Risperidone (for negative symptoms in psychosis)

Methylphenidate, Dextroamphetamine, and L-Dopa give best results in mild to moderate impairments such as mild post-concussion syndrome.

Psychostimulants are best for mild impairment with decreased attention and memory, apathy and anergy.

Other dopamine agonists are useful in more severe impairments.

Presynaptic dopamine agonists:

Methylphenidate, Dextroamphetamine, Adderall, L-Dopa

Postsynaptic dopamine agonists:

Bromocriptine (mixed), Pergolide, Amantadine (mixed)

Other antidepressants:

Imipramine, Desipramine, Amitriptyline

ATTENTION DEFICIT / HYPERACTIVITY:

Bupropion, Buspirone, Other antidepressants, Carbamazepine

Psychostimulants

Methylphenidate, Dextroamphetamine, Adderall, Magnesium pemoline

Beta-adrenergic blockers

Inderal, Pindolol,

Clonidine .05-.1mg bid, increasing by .1mg/d to 2.4 mg/d maximum

(hypervigilance, hyperactivity)

HYPERVIGILANCE AND HYPERACTIVITY:

Clonidine

EMOTIONAL INCONTINENCE/PATHOLOGICAL LAUGHING OR CRYING:

Amitriptyline, Amantadine, L-Dopa, Fluoxetine, Carbamazepine

AUTONOMIC DYSREGULATION:

(hyperthermia, diaphoresis, tachycardia, tachypnea)

Bromocriptine, Dantrolene sodium

COGNITION: Cognitive impairment in TBI. First evaluate side effects of current medications-- anticholinergic, antihistaminic, sedative. These could lead to impaired memory, attention and concentration.

Naltrexone, Ergoloid mesylates, Nimodipine, Nicotine, Donepezil

CONCEPTUAL DISORDERS:

PSYCHOSIS:

Neuroleptics

Fluphenazine, Clozaril, Risperidone, Olanzepine, Quetiapine

Anticonvulsants

MONOSYMPTOMATIC DELUSIONS, PATHOLOGICAL JEALOUSY:

Pimozide, Fluoxetine

EATING DISORDERS:

OVEREATING:

Fluoxetine, Trazodone, Naltrexone, Sibutramine

LACK OF APPETITE :

Cyproheptadine

EXCESSIVE WATER DRINKING :

Demeclocycline (600 mg bid), Lithium carbonate, Captopril (12.5 mg/d)

MOOD DISORDERS:

DEPRESSION:

Incidence of post-TBI depression:15 - 25%. Depression may occur without a feeling of sadness. It may manifest as agitation, irritability, lack of pleasure, impaired cognition.

 

Antidepressants:

Desipramine (not sedating), Nortriptyline (sedating), Bupropion (low anticholinergic and antihistaminic side effects; activating), Trazodone (sedating), Fluoxetine, Sertraline, Paroxetine (low anticholinergic and antihistaminic side effects; activating), Amoxapine (metabolized to neuroleptic), Nefazodone (lower incidence of insomnia, GI upset, weight gain), Mirtazapine, Venlafaxine, Selegiline (MAOI, no dietary restriction when used at Parkinson's Disease doses of 5-10mg/d; antidepressant doses, 15-60 mg/d, require low tyramine diet; metabolized to amphetamine)

Psychostimulants

Methylphenidate, Dextroamphetamine, Magnesium pemoline, Adderall

TREATMENT- RESISTANT OR PARTIALLY RESPONSIVE DEPRESSIONS:

(a) Increase dose until benefits or side effects appear

(b) Change to another antidepressant

(c) Add a second antidepressant

(d) Augment antidepressants with: Buspirone, Lithium Carbonate, Thyroxine, Tri-iodothyronine, Atypical Neuroleptic, Anticonvulsant, Pindolol

MANIC DISORDER :

Lithium Carbonate

Anticonvulsants

Carbamazepine, Valproic acid, Clonazepam, Gabapentin, Lamotrigine

Calcium Channel Blockers

Verapamil, Diltiazem, Nifedipine, Nimodipine

Neuroleptics

(If single agent ineffective, consider low dose Lithium + anticonvulsants +/or neuroleptic)

POST-TRAUMATIC HEADACHES:

Nonsteroidal anti-inflammatories (NSAIDs) Antidepressants (tricyclic)

Calcium channel blockers

Verapamil, Diltiazem, Nifedipine, Nimodipine (selective for cerebral vasculature) Phenylzine (MAOI antidepressant)

MOVEMENT DISORDERS:

ABSENCE OF MOVEMENTS AFTER TBI:

Neostigmine, Physostigmine, Bromocriptine, Amantadine

INCOORDINATION

L-trytophan, Thyrotropin-releasing hormone (oral), Propranolol,

Gamma-vinyl GABA, Acetazolamide, Phthalazinol

DYSTONIA :

Dopamine agonists: Bromocriptine, L-dopa

Anticholinergics: Benztropine, Trihexyphenidyl

Baclofen

Benzodiazepines: Diazepam, Alprazolam, Lorazepam

Carbamazepine

TREMORS:

Beta-adrenergic blockers: Propranolol, Atenolol, Pindolol

Benzodiazepines, Dopamine agonists, Valproic acid, Anticholinergics, Isoniazide

PARKINSONISM:

(bradykinesia, dysarthria, decreased facial expression, rigidity)

Selegiline, L-Dopa, Pergolide, Bromocriptine

AKATHISIA:

Bromocriptine, Propranolol,Cyproheptadine

MYOCLONUS:

Clonazepam,Trazodone, L-Tryptophan, Valproic acid, Primidone, Piracetam

DYKINESIAS:

Dopamine agonists, Anticonvulsants

NEUROGENIC HETEROTOPIC OSSIFICATION:

Etidronate disodium, Nonsteroidal anti-inflammatory meds (NSAIDs)

OBSESSIVE-COMPULSIVE DISORDER:

Fluoxetine, Sertraline, Paroxetine, Clomipramine (May add Buspirone or atypical neuroleptic to antidepressant )

PERCEPTUAL DISORDERS:

HEMI-INATTENTION / NEGLECT:

Bromocriptine

SEIZURE DISORDERS:

Carbamazepine (partial seizures, simple or complex) Valproic acid (multi-focal or generalized seizures), Gabapentin (metabolized by kidneys), Lamotrigine, Topiramate

SEXUAL DISORDERS:

HYPOSEXUALITY:

Antidepressants, Yohimbine, Testosterone, Sildenafil

HYPERSEXUALITY:

Females:

(Sexual assault, frequent masturbation, violent erotic dreams, with normal testosterone levels)

Cyproterone acetate (androgen receptor blocker) 25-50 mg/d (days 5-15 of menstrual cycle) Ethinyl estradiol 50 mcg/day (days 5-25 of menstrual cycle)

Males:

Medroxyprogesterone im: approx. 200 mg im/week decreasing to 200mg/mo with testosterone level maintained at 100 po: 60-200mg/d (fewer side effects with low dose p.o. than i.m.)

Depo-leuprolide acetate 7.5 mg im/mo, Cyproterone acetate 50mg bid, Conjugated estrogens

Both males and females: fluoxetine and other serotonin re-uptake inhibitors ( reduced sex drive and function in 30% )

SLEEP DISORDERS:

NARCOLEPSY:

Fluoxetine, Psychostimulants

INSOMNIA:

Antidepressants (sedating), Valproic acid, Zolpidem, Clonazepin

SPEECH - LANGUAGE DISORDERS:

MUTISM:

Physostigmine 1 mg i.m. one time weekly x three weeks

Bromocriptine 2.5-5 mg twice daily up to 45 mg/day (increase the dose about every one month) Imipramine

DYSPHAGIA:

L-dopa

DYSPHASIA:

Bromocriptine

DYSARTHRIA:

Clonazepam

About the author:

Daniel Gardner, MD is in the private practice of psychiatry, psychoanalysis, and neurobehavioral medicine in San Diego and Solana Beach, California. He provides treatment (problem solving, skill building, and medication management) and consults on quality of care issues with TBI survivors, their families, health care providers, health care organizations, and insurance companies.

He is Assistant Clinical Professor of Psychiatry, UCSD School of Medicine and faculty member, San Diego Psychoanalytic Society and Institute. He was formerly medical director of NeuroCare at Stone Mountain, a post-acute brain injury rehabilitation program and is currently medical director of Hidden Valley Rehabilitation Services, a neurologic disabilities rehabilitation program in Ramona, California.

4550 Kearny Villa Rd., Ste. 214 San Diego, CA 92123

993-E Lomas Santa Fe Drive Solana Beach, CA 92075

Phone/fax: 858 560 5609

 

 

Return to the top of the page

San Diego Brain Injury Foundation
Email: Director of Operations
P.O. Box 84601
San Diego, California 92138-4601
(619) 294-6541

Web publishing by Web publishing by GoThere Corporation

Web Publishing by GoThere.com